Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Journal of Wildlife Diseases|October 30, 2008
Occurrence of mycoplasmas in free-ranging birds of prey in GermanyM Lierz, N Hagen, S J Hernadez-Divers, et al.Cell Death and Differentiation|February 19, 2011
Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanismN Hagen, M Hans, D Hartmann, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 25, 2002
Characterization of mixtures of recombinant human cytochrome p450s as a screening model for metabolic stability in drug discoveryN Hagen, A K Olsen, J V Andersen, et al.Current Oncology (Toronto, Ont.)|April 20, 2012
Characterizing distress, the 6th vital sign, in an oncology pain clinicA Waller, S L Groff, N Hagen, et al.Health Promotion International|May 7, 2004
A review of school drug policies and their impact on youth substance useTracy Evans-Whipp, Jennifer M Beyers, Sian Lloyd, et al.Journal of the American Academy of Child and Adolescent Psychiatry|April 11, 2007
Pubertal stage and deliberate self-harm in adolescentsGeorge C Patton, Sheryl A Hemphill, Jennifer M Beyers, et al.Journal of Clinical Pharmacology|January 1, 1995
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphoneN Hagen, M P Thirlwell, H S Dhaliwal, et al.Journal of Pain and Symptom Management|June 1, 1997
A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and painD S Ernst, P Brasher, N Hagen, et al.Cancer|September 15, 1994
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painH Hays, N Hagen, M Thirlwell, et al.Pageof 9